4th TGF-B Targeted Drug Development Summit

Temi della conferenza
With 128 TGF-B targeted therapies in the clinic and 68 in the preclinical stage, the TGF-B field is currently being rejuvenated by novel approaches in immuno-oncology, and cutting edge research in fibrosis, autoimmune diseases, and beyond.

Professional congress organizer (PCO)
Hanson Wade

Annotazioni
URL:
Brochure: https://go.evvnt.com/2479168-3?pid=4832

Speakers: Alessandra Castiglioni, Senior Scientific Manager, Genentech, Anthony Conley, Associate Professor, MD Anderson Cancer Center, and more

https://go.evvnt.com/2479168-2?pid=4832

Ms. Isabel Weir